• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于扩展药效团特征的多巴胺 D1 和 D2 完全激动剂的选择性药效团模型。

Selective pharmacophore models of dopamine D(1) and D(2) full agonists based on extended pharmacophore features.

机构信息

Department of Chemistry, Medicinal Chemistry, University of Gothenburg, 41296 Göteborg, Sweden.

出版信息

ChemMedChem. 2010 Feb 1;5(2):232-46. doi: 10.1002/cmdc.200900398.

DOI:10.1002/cmdc.200900398
PMID:20077461
Abstract

This study is focused on the identification of structural features that determine the selectivity of dopamine receptor agonists toward D(1) and D(2) receptors. Selective pharmacophore models were developed for both receptors. The models were built by using projected pharmacophoric features that represent the main agonist interaction sites in the receptor (the Ser residues in TM5 and the Asp in TM3), a directional aromatic feature in the ligand, a feature with large positional tolerance representing the positively charged nitrogen in the ligand, and sets of excluded volumes reflecting the shapes of the receptors. The sets of D(1) and D(2) ligands used for modeling were carefully selected from published sources and consist of structurally diverse, conformationally rigid full agonists as active ligands together with structurally related inactives. The robustness of the models in discriminating actives from inactives was tested against four ensembles of conformations generated by using different established methods and different force fields. The reasons for the selectivity can be attributed to both geometrical differences in the arrangement of the features, e.g., different tilt angels of the pi system, as well as shape differences covered by the different sets of excluded volumes. This work provides useful information for the design of new D(1) and D(2) agonists and also for comparative homology modeling of D(1) and D(2) receptors. The approach is general and could therefore be applied to other ligand-protein interactions for which no experimental protein structure is available.

摘要

本研究致力于确定多巴胺受体激动剂对 D(1)和 D(2)受体选择性的结构特征。为这两种受体开发了选择性药效团模型。这些模型是通过使用代表受体中主要激动剂相互作用位点的投影药效特征构建的(TM5 中的 Ser 残基和 TM3 中的 Asp)、配体中的一个方向性芳香特征、一个具有较大位置容忍度的特征,代表配体中的带正电荷的氮,以及反映受体形状的一组排除体积。用于建模的 D(1)和 D(2)配体集是从已发表的来源中精心挑选的,由结构多样、构象刚性的全激动剂作为活性配体与结构相关的非活性配体组成。通过使用不同的已有方法和不同的力场生成的四个构象集,测试了模型区分活性和非活性配体的稳健性。选择性的原因可以归因于特征排列的几何差异,例如,pi 系统的不同倾斜角度,以及不同排除体积集覆盖的形状差异。这项工作为设计新的 D(1)和 D(2)激动剂提供了有用的信息,也为 D(1)和 D(2)受体的比较同源建模提供了信息。该方法具有通用性,因此可应用于其他尚无实验蛋白质结构的配体-蛋白质相互作用。

相似文献

1
Selective pharmacophore models of dopamine D(1) and D(2) full agonists based on extended pharmacophore features.基于扩展药效团特征的多巴胺 D1 和 D2 完全激动剂的选择性药效团模型。
ChemMedChem. 2010 Feb 1;5(2):232-46. doi: 10.1002/cmdc.200900398.
2
CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.基于比较分子力场分析(CoMFA)对重组D1和D2多巴胺受体激动剂亲和力的预测
J Med Chem. 1998 Oct 22;41(22):4385-99. doi: 10.1021/jm9800292.
3
Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping.D1多巴胺受体激动剂的构象分析:药效团评估与受体图谱分析
J Med Chem. 1996 Jan 5;39(1):285-96. doi: 10.1021/jm9502100.
4
Investigation of D₁ receptor-agonist interactions and D₁/D₂ agonist selectivity using a combination of pharmacophore and receptor homology modeling.使用药效基团和受体同源建模相结合的方法研究 D₁ 受体激动剂相互作用和 D₁/D₂ 激动剂选择性。
ChemMedChem. 2012 Mar 5;7(3):483-94, 338. doi: 10.1002/cmdc.201100546. Epub 2012 Feb 7.
5
Molecular modeling of interactions between tetrahydroprotoberberines and dopamine receptors.四氢原小檗碱与多巴胺受体相互作用的分子模拟
Zhongguo Yao Li Xue Bao. 1996 Jan;17(1):8-12.
6
8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms.8,9 - 二羟基 - 1,2,3,11b - 四氢色烯并[4,3,2 - de]异喹啉(地诺昔林),对所有多巴胺受体亚型均为高亲和力且强效的激动剂。
Bioorg Med Chem. 2004 Mar 15;12(6):1403-12. doi: 10.1016/j.bmc.2004.01.008.
7
9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.9-二羟基-2,3,7,11b-四氢-1H-萘并[1,2,3-de]异喹啉:一种强效的多巴胺D1完全激动剂,含有刚性β-苯基多巴胺药效团。
J Med Chem. 1996 Jan 19;39(2):549-55. doi: 10.1021/jm950707+.
8
Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.强效且高选择性D3受体配体的合成与药理学评价:对觅可卡因行为的抑制作用以及多巴胺D3/D2受体的作用
J Med Chem. 2003 Aug 28;46(18):3822-39. doi: 10.1021/jm0211220.
9
Characterization of the 5-HT(7) receptor. Determination of the pharmacophore for 5-HT(7) receptor agonism and CoMFA-based modeling of the agonist binding site.
J Med Chem. 2003 Dec 4;46(25):5365-74. doi: 10.1021/jm030826m.
10
Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.通过同源分子建模和使用嵌合肽配体进行验证来鉴定假定的刺鼠相关蛋白(87-132)-促黑素皮质素4受体相互作用。
J Med Chem. 2004 Apr 22;47(9):2194-207. doi: 10.1021/jm0303608.

引用本文的文献

1
MTMol-GPT: De novo multi-target molecular generation with transformer-based generative adversarial imitation learning.MTMol-GPT:基于生成式对抗模仿学习的新型多靶点分子生成
PLoS Comput Biol. 2024 Jun 26;20(6):e1012229. doi: 10.1371/journal.pcbi.1012229. eCollection 2024 Jun.
2
Identification of Novel Dopamine D Receptor Ligands-A Combined In Silico/In Vitro Approach.新型多巴胺 D 受体配体的鉴定——一种计算机辅助/体外结合方法。
Molecules. 2022 Jul 11;27(14):4435. doi: 10.3390/molecules27144435.
3
In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.
针对帕金森病药物研究的 G 蛋白偶联受体的计算机研究。
Curr Neuropharmacol. 2018;16(6):786-848. doi: 10.2174/1570159X16666180308161642.
4
Tetrahydroisoquinolines functionalized with carbamates as selective ligands of D2 dopamine receptor.用氨基甲酸酯官能化的四氢异喹啉作为D2多巴胺受体的选择性配体。
J Mol Model. 2017 Sep 2;23(9):273. doi: 10.1007/s00894-017-3441-6.
5
Functional roles of T3.37 and S5.46 in the activation mechanism of the dopamine D1 receptor.T3.37和S5.46在多巴胺D1受体激活机制中的功能作用。
J Mol Model. 2017 Apr;23(4):142. doi: 10.1007/s00894-017-3313-0. Epub 2017 Mar 31.
6
Identification of the Beer Component Hordenine as Food-Derived Dopamine D2 Receptor Agonist by Virtual Screening a 3D Compound Database.通过虚拟筛选三维化合物数据库鉴定啤酒成分霍多宁为食物来源的多巴胺 D2 受体激动剂。
Sci Rep. 2017 Mar 10;7:44201. doi: 10.1038/srep44201.
7
Revision of the classical dopamine D2 agonist pharmacophore based on an integrated medicinal chemistry, homology modelling and computational docking approach.基于整合药物化学、同源建模和计算对接方法对经典多巴胺D2激动剂药效团的修订。
Neurochem Res. 2014 Oct;39(10):1997-2007. doi: 10.1007/s11064-014-1314-2. Epub 2014 Jul 24.
8
Development of 7TM receptor-ligand complex models using ligand-biased, semi-empirical helix-bundle repacking in torsion space: application to the agonist interaction of the human dopamine D2 receptor.使用扭能空间中具有配体偏向性的半经验螺旋束重新包埋技术构建 7TM 受体-配体复合物模型:在人类多巴胺 D2 受体激动剂相互作用中的应用。
J Comput Aided Mol Des. 2013 Mar;27(3):277-91. doi: 10.1007/s10822-013-9640-z. Epub 2013 Apr 4.
9
Investigation of D₁ receptor-agonist interactions and D₁/D₂ agonist selectivity using a combination of pharmacophore and receptor homology modeling.使用药效基团和受体同源建模相结合的方法研究 D₁ 受体激动剂相互作用和 D₁/D₂ 激动剂选择性。
ChemMedChem. 2012 Mar 5;7(3):483-94, 338. doi: 10.1002/cmdc.201100546. Epub 2012 Feb 7.
10
Investigation of D₂ receptor-agonist interactions using a combination of pharmacophore and receptor homology modeling.运用药效基团和受体同源建模的组合方法研究 D₂ 受体激动剂相互作用。
ChemMedChem. 2012 Mar 5;7(3):471-82, 338. doi: 10.1002/cmdc.201100545. Epub 2012 Feb 7.